Dr. Osifo-Dawodu is an entrepreneur, strategist, and visionary. Trained as a physician, she identified early the importance of utilizing management and financial levers to improve health outcomes for populations.  Her understanding of management and finance beyond healthcare, and her ability to identify early health (including the impact of COVID) and social trends, and risks have made her a highly sought adviser by CEOs, boards, and senior leaders in both the public and private sectors in more than 27 countries. 

Her unique expertise in understanding organizations and people, while focusing on key technical and financial issues has enabled her to be an effective board member, working collaboratively with the CEO and other board members at MedAccessUK. The company provides volume guarantees and/or debt to mainly pharmaceutical and medical device companies e.g.  GlaxoSmithKline, BASF etc. to accelerate entry of products in emerging markets. She is currently the Chair of the People and Remuneration and a member of the Audit and Risk committees of MedAccessUK. 

Dr. Osifo-Dawodu is also a member of the Healthcare Advisory Council of British International Investment (which has directly deployed over $400 million in equity to India and Africa and is a Limited Partner in several Private Equity Funds with over $1.4 billion in investable capital). She was previously an advisory board member of Sproxil (recognized by Fast Company as one of the most World's 50 Most Innovative Companies)  the Mayo Clinic Center for social media and recognized by Harvard Business School/Scriplogix as one of the most innovative leaders in healthcare. She is also a member of the investment committee of a Health PE fund.

As a founding Partner of the Anadach Group where she leads the Management Consulting and Health Financing Advisory work, she has significant experience on governance and board issues.  Her clients include several leading global organizations such as Pfizer Inc and the International Finance Corporation, financial institutions including several private equity funds, hospitals/healthcare facilities as well as smaller fast-growing organizations. 

She  co-authored a chapter on “Boards and Governance” in a recently published book “The Global Healthcare Manager: Competencies, Concepts, and Skills.”  Her uncanny ability to identify future trends allowed her to identify technology as a major driver for the health industry, over 20 years ago leading the assessment of a potential IFC investment in biotechnology in a New York based Private Equity Fund and was an adviser to the CEO of a US-based tech-enabled health company focusing on leveraging technology to expand services available to older adults in a location-agnostic manner including its provision of COVID services for over 80 retirement homes across the US during the pandemic.

With her 30+ years of professional experience including 16 years at the World Bank Group (including managerial and technical roles), working both with senior private and public sector leaders across  Asia, Africa,  Europe, Latin America, the Middle East, and the USA she has an effective wide global network which she has leveraged for her previous board engagements.  Dr. Osifo-Dawodu is recognized as a leader and is often invited to speak at conferences, strategic discussions, and board retreats, or interviewed on various health, pharmaceutical, or technology issues.  She often is invited to lecture at leading universities including Columbia, Johns Hopkins, etc. and her work has been published in top academic journals. She also has working competency in French.